|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02526 DIAGENS-B
Nominal 
() | 2025/12 - Final RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (29,777) | (47,395) |
| Net Cash from / (used in) Investing Activities | -- | 19,657 | (117,055) |
| Net Cash from / (used in) Financing Activities | -- | 6,805 | 163,982 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (3,315) | (468) |
| Cash & Cash Equivalents at beginning of period | -- | 20,419 | 20,887 |
| Effect of Foreign Exchange Rate Changes | -- | 0 | 0 |
| Others | -- | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 17,104 | 20,419 |
| Remarks: | Real time quote last updated: 26/03/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -67,137 |
| %Change | 54.783% |
| EPS / (LPS) | RMB -- |
| NBV Per Share (¥) | RMB -- |